oa Erectile dysfunction: An update of diagnosis and management

References

1. Feldman HAGoldstein IHatzichriston DGKrane RJMckinlay JB. Impotence and its medical and psychological correlates: results of the Massachusettes Male Aging Study. J Urol. 1994; 151:54–61.
   [Google Scholar]
2. Treating erectile dysfunction: a physician's guide. Pfizer pharmaceuticals monogram, Pfizer Inc., New York; 1998.
3. Laumann EOPaik ARosen RC. Sexual dysfunction in the United States; prevalence and predictors. JAMA. 1999; 281::537–544.
   [Google Scholar]
4.   NIH Consensus Development Panel on Impotence. JAMA. 1993; 270::83–90.
   [Google Scholar]
5. Krauss D. The physiologic basis of male sexual dysfunction. Hosp. Pract. 1983; 2::193–222.
   [Google Scholar]
6. Lerner SEMelman AChrist GJ. A review of erectile dysfunction: new insignht and more questions. J Urol. 1993; 149::1246–1255.
   [Google Scholar]
7. Lo Piccolo JDaiss S. Contemporary Management of Impotence and Infertility. In: Tanagho EALue TFMcClure RD, eds. Baltimore: Williams & Wilkins 1988;:104–107.
8. Masters WJohnson V. Human sexual inadequacy. Boston: Little, Brown & Co. 1970.
   [Google Scholar]
9. Spark RWhite RConnoly P. Impotence is not always psychogenic. New insights into hypothalamic-pituitary-gonadal dysfunction. JAMA. 1980; 243::750–755.
   [Google Scholar]
10. Bancroft J. Testosterone therapy for low sexual interest and erectile dysfunction in man: a controlled study. Br J Psychiatry. 1984; 14::146–151.
    [Google Scholar]
11. Seagraves RSchoenberg HZarins CKnopf JCarnic P. Discrimination of organic versus psychological impotence with the DSFI: a failure to replicate. J Sex Marital Ther. 1981; 7::230–238.
    [Google Scholar]
12. Carrier SBrock GKour NWLue TF. Pathophysiology of erectile dysfunction. Urology. 1993; 42::468–481.
    [Google Scholar]
13. Benet AEMelman A. The epidemiology of erectile dysfunction. Urol Clin North Am. 1995; 22::699–709.
    [Google Scholar]
14. Weirman MECasel CK. Erectile dysfunction: a multifaceted disorder. Hosp Pract. Oct. 1998; 18::65–90.
    [Google Scholar]
15. Bartlik BCocsis JHLegere R et al. Sexual dysfunctions secondary to depressive disorders. J Sex Marital Ther. 1999; 2:2:52–60.
    [Google Scholar]
16. Shah sigh R. Is a drug effect part of your patient's complaint of impotence ? Contemp Urol. 1993; 5::51–58.
    [Google Scholar]
17. Finger WWLung MStagle MA. Medications that may contribute to sexual disorders. J Fam Pract. 1997; 44::33–43.
    [Google Scholar]
18. Merrill JMLaux LFThornby JI. Why doctors have difficulty with sex histories. South Med J;. 1990; 83::613–617.
    [Google Scholar]
19. Tudiver FTalbot Y. Why don't men seek help ? Family physicians perspectives on help-seeking behavior in men. J Fam Pract. 1999; 48::47–52.
    [Google Scholar]
20. Rosen RCRiley AWagner GOsterloh IHKirkpatrick JMishra A. The International Index of Erectile Function (IIEF): a multidimentional scale for assessment of erectile dysfunction. Urology. 1997; 49::822–830.
    [Google Scholar]
21. Lue TF. Impotence: a patient's goal-directed approach to treatment. World J Urol. 1990; 8::67–74.
    [Google Scholar]
22. Althof SESefte AD. The evaluation and management of erectile dysfunction. Psychiatr Clin North Am. 1995; 18::171–191.
    [Google Scholar]
23. Gunnarsson OTJudge JO. Exercise at midlife: how and why to prescribe it for sedentary patients. Geriatrics. 1997; 52::71–80.
    [Google Scholar]
24. Muller JEMittleman MAMaclure M et al. Triggering myocardial infarction by sexual activity. JAMA. 1996; 275::1405–1409.
    [Google Scholar]
25. Goldstein IKue TFPadma-Nathan HRosen RCSteers WCWickers PA. for the sildenafil study group. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998; 338::1397–1404.
    [Google Scholar]
26. Cheitlin MDHutter AMBrindis RG et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. ACC/AHA Expert Consensus Document. J Am Coll Cardiol. 1999; 33::273–282.
    [Google Scholar]
27. Nicker son MCollier B. Drugs inhibiting adrenergic nerves and structures innervated by them. In: Goodman LGilman A, eds. The pharmacological basis of therapeutics. New York: McMillan 1975;:533–564.
    [Google Scholar]
28. Kunelius PHakkinen JLukkarinen O. Is high-dose yohimbine hydrochloride effective in the treatment of mixed-type impotence ? Urology. 1997; 49::441–444.
    [Google Scholar]
29. Porst H. The rationale for prostaglandin E] in erectile failure: a survey of worldwide experience. J Urol. 1996; 155::802–815.
    [Google Scholar]
30. Padma-Nathan HHellstrom WJKaiser FE et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med. 1997; 336::1–7.
    [Google Scholar]
31. Brindly GS. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. Br J Psychiatry. 1983; 143::332–339.
    [Google Scholar]
32. Linet 01Prince FG for the alprostadil study group . Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996; 334::873–877.
    [Google Scholar]
33. Mulhall JPJahoda AECairney M et al. The causes of patient dropout from penile self injection therapy for impotence. J Urol. 1999; 162:4:1291–1294.
    [Google Scholar]